Several Native tribes make COVID-19 vaccines available to everyone in Oklahoma
The Chickasaw, Choctaw, Osage, Cherokee, and Potawatomi nations are offering vaccinations to anyone in Oklahoma who needs one.
Public health & disease
From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.
Once-a-month PrEP pill shows promising results for HIV prevention
Islatravir, an HIV prevention drug developed by Merck, has already reached its second stage of trials. Following promising results, it looks likely to go to Phase 3 trials, bringing it one step closer to approval.
U.S. counties with more cannabis dispensaries are suffering fewer opioid deaths
A new study out of UC Davis suggests that increased access to cannabis stores that legally sell medical and recreational cannabis may help to reduce opioid-related deaths.
New prostate cancer test makes diagnosis in 20 minutes with near 100% accuracy
The breakthrough, developed by Korean scientists, is likely to revolutionize testing as existing methods are not only inaccurate but can result in over-diagnosis and necessitate invasive biopsies.
German scientists make paralyzed mice walk again
German researchers have enabled mice paralyzed after spinal cord injuries to walk again, re-establishing a neural link hitherto considered irreparable in mammals.
U.S. FDA approves first-ever long-acting HIV medication
The monthly injection treatment replaces the need for some to take daily pills. The company says the price of the injections is comparable to the cost of the pill versions.
Psychedelic research center launched at New York’s Mount Sinai
Named the Center for Psychedelic Psychotherapy and Trauma Research the institution is first focusing on MDMA-assisted psychotherapy for PTSD.
U.N. reclassifies cannabis as a less dangerous drug
Cannabis is no longer classified as a Schedule IV drug as per WHO’s recommendation. The declassification opens up the door for more research into its medicinal and therapeutic uses.
Phase 1 human trial for universal flu vaccine reports promising results
The Phase 1 trial, led by researchers from the Icahn School of Medicine at Mount Sinai, found this experimental vaccine to be both safe and effective at generating a long-term immune response in a small number of healthy adults.
First of-its-kind study suggests psilocybin can help treat migraines
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks.